HK1210035A1 - Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same - Google Patents

Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same

Info

Publication number
HK1210035A1
HK1210035A1 HK15110855.6A HK15110855A HK1210035A1 HK 1210035 A1 HK1210035 A1 HK 1210035A1 HK 15110855 A HK15110855 A HK 15110855A HK 1210035 A1 HK1210035 A1 HK 1210035A1
Authority
HK
Hong Kong
Prior art keywords
aqueous dispersion
encapsulating liposome
liposome aqueous
stable oxaliplatin
stabilizing same
Prior art date
Application number
HK15110855.6A
Other languages
English (en)
Chinese (zh)
Inventor
祐輔 土井
竜弘 石田
Original Assignee
Taiho Pharmaceutical Co Ltd
Univ Tokushima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd, Univ Tokushima filed Critical Taiho Pharmaceutical Co Ltd
Publication of HK1210035A1 publication Critical patent/HK1210035A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15110855.6A 2012-08-10 2015-11-03 Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same HK1210035A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012178971 2012-08-10
PCT/JP2013/071720 WO2014025042A1 (fr) 2012-08-10 2013-08-09 Dispersion aqueuse de liposome encapsulant un oxaliplatine stable, et procédé de stabilisation

Publications (1)

Publication Number Publication Date
HK1210035A1 true HK1210035A1 (en) 2016-04-15

Family

ID=50068258

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110855.6A HK1210035A1 (en) 2012-08-10 2015-11-03 Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same

Country Status (8)

Country Link
US (2) US10383822B2 (fr)
EP (1) EP2883542B1 (fr)
JP (1) JP6230538B2 (fr)
CN (1) CN104703594B (fr)
ES (1) ES2733061T3 (fr)
HK (1) HK1210035A1 (fr)
SG (2) SG10201701063WA (fr)
WO (1) WO2014025042A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6341987B2 (ja) * 2013-03-13 2018-06-13 マリンクロッド エルエルシー がん治療のためのリポソームオキサリプラチン組成物
SI3350222T1 (sl) 2015-09-18 2022-01-31 Technische Universitaet Muenchen Ligandi za integrin avbeta6, sinteza in uporaba le-teh
TWI787201B (zh) 2016-08-31 2022-12-21 日商富士軟片股份有限公司 抗腫瘤劑、抗腫瘤效果增強劑及抗腫瘤用套組
US11332498B2 (en) 2017-03-17 2022-05-17 Technische Universitat Munchen Ligands for integrin αVβ8, synthesis and uses thereof
MX2018002611A (es) 2018-01-29 2019-07-30 Fujifilm Corp Agente antitumoral para cancer del tracto biliar y metodo para tratar cancer del tracto biliar.
WO2019176984A1 (fr) * 2018-03-13 2019-09-19 富士フイルム株式会社 Agent anti-tumoral, potentialisateur d'effet anti-tumoral et kit anti-tumoral

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1270198A (fr) 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation d'agents antineoplastiques dans des liposones
JP3218637B2 (ja) 1990-07-26 2001-10-15 大正製薬株式会社 安定なリポソーム水懸濁液
CA2184834A1 (fr) * 1994-03-11 1995-09-14 Yoshiyuki Mori Preparation de liposome
CN1138541C (zh) 1994-08-08 2004-02-18 德彪药品股份有限公司 一种药学上稳定的奥沙利铂制剂
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
DE19648650C2 (de) 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung
US20010006648A1 (en) 1996-02-26 2001-07-05 Hitoshi Yamauchi Liposomes and liposomal dispersion
WO1997048398A1 (fr) 1996-06-18 1997-12-24 Kyowa Hakko Kogyo Co., Ltd. Preparations liposomes de derives indolocarbazole
JP4368513B2 (ja) 1999-12-27 2009-11-18 富士フイルム株式会社 画像処理方法および装置並びに記録媒体
JP3415131B1 (ja) 2002-06-03 2003-06-09 メビオファーム株式会社 リポソーム製剤
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
US20040002284A1 (en) * 2002-06-27 2004-01-01 Leal Jose E. Illuminated throwing toy
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
EP1746976B1 (fr) * 2004-05-03 2017-01-11 Merrimack Pharmaceuticals, Inc. Liposomes utiles pour l'administration de medicaments
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US8078919B2 (en) * 2005-06-14 2011-12-13 Hitachi Global Storage Technologies Netherlands B.V. Method, apparatus and program storage device for managing multiple step processes triggered by a signal
GR20060100144A (el) 2006-03-03 2007-10-17 Θεραπεια του καρκινου με χρηση οξαλιπλατινης εγκλεισμενης μεσα σε λιποσωματα και απο κοινου εγκλεισμος στο λιποσωμιακο μοριο περισσοτερων απο ενος φαρμακευτικου παρασκευασματος h gene
WO2008030818A2 (fr) 2006-09-05 2008-03-13 Mebiopharm Co., Ltd. Nouvelles compositions de liposomes
TWI468188B (zh) 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
EP2123258A1 (fr) 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes pour l'administration de médicaments

Also Published As

Publication number Publication date
SG10201701063WA (en) 2017-04-27
US20150216801A1 (en) 2015-08-06
WO2014025042A1 (fr) 2014-02-13
EP2883542A1 (fr) 2015-06-17
EP2883542B1 (fr) 2019-05-01
CN104703594A (zh) 2015-06-10
ES2733061T3 (es) 2019-11-27
US10993913B2 (en) 2021-05-04
SG11201501010QA (en) 2015-04-29
CN104703594B (zh) 2018-01-23
EP2883542A4 (fr) 2016-01-06
US20190321294A1 (en) 2019-10-24
JPWO2014025042A1 (ja) 2016-07-25
JP6230538B2 (ja) 2017-11-15
US10383822B2 (en) 2019-08-20

Similar Documents

Publication Publication Date Title
HK1204809A1 (en) Autopilot and methods
IL238250B (en) Selective antisense compounds and their use
ZA201409071B (en) Controlled environment and method
GB2500915B (en) Arrangement and method
EP2898720A4 (fr) Systèmes et procédés d'alignement de brouillage en wifi
HK1213131A1 (zh) 用於間斷接收的方法和裝置
EP2866390A4 (fr) Procédé et système de communication
EP2825142A4 (fr) Systèmes et procédés de stabilisation d'équilibre
HK1200384A1 (en) Pressure-regulating vial adaptors and methods
HK1200339A1 (en) W/o/w emulsion having long-term stability and method for producing same w/o/w
EP2898728A4 (fr) Système et procédé de communication
HK1210035A1 (en) Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same
EP2762538A4 (fr) Dispersion aqueuse et son procédé de fabrication
EP2927807A4 (fr) Procédé d'activation d'un terminal, et terminal
GB2509397B (en) Rigid-stem active method and system
EP2774602A4 (fr) Dispersion aqueuse et son procédé de fabrication
GB201223260D0 (en) Methods and apparatuses for facilitating communications
EP3041901A4 (fr) Dispersion aqueuse de polyuréthane
EP2873709A4 (fr) Procédé de production d'une dispersion protégeant des rayons caloriques, dispersion ainsi obtenue, et corps protégeant des rayons caloriques
HK1201575A1 (en) Aqueous assembly and control method
ZA201504003B (en) Stabilizing system
PT2812291T (pt) Dispersão aquosa
EP2894197A4 (fr) Dispersion aqueuse, et additif destinés au travail de fracturation
EP2805956A4 (fr) Dérivés d'acide gambogique, procédé de préparation et application de ceux-ci
SG11201500474PA (en) Nutriculture member and nutriculture method

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220804